Last reviewed · How we verify
Acid Reflux Relief (Sodium Phosphate, Dibasic, Heptahydrate)
Sodium Phosphate, Dibasic, Heptahydrate is a marketed drug by Pfizer Inc. It is used to preserve purity and is taken under the tongue before meals or as needed. The exact mechanism of action is not specified on Wikipedia. This drug has 2 trials and 6 publications. It is a significant commercial entity with $63.6B in revenue. There is limited information available on its clinical differentiation and pipeline developments.
At a glance
| Generic name | Sodium Phosphate, Dibasic, Heptahydrate |
|---|---|
| Sponsor | Pfizer |
| Drug class | Non-Standardized Plant Allergenic Extract [EPC] |
| Target | Carbonic anhydrase 4 |
| Phase | FDA-approved |
| First approval | 1983 |
Approved indications
- To preserve purity avoid touching pellets with fingers
- Take apart from food or drinks
- To dissolve under your tongue before meals or as needed
Common side effects
- Visual Acuity Reduced
- Ocular Hypertension
- Back Pain
- Hypoaesthesia
- Infection
- Posterior Capsule Opacification
- Vomiting
- Weight Decreased
- Eye Pain
- Limb Injury
- Vitreous Haemorrhage
- Upper Respiratory Tract Inflammation
Drug interactions
- Antacids
- Calcium supplements
- Magnesium-containing antacids
- Potassium-containing medications
- Tetracyclines
- Quinolones
- Iron supplements
- Corticosteroids
- Diuretics
- Laxatives
Key clinical trials
- A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab (PHASE1, PHASE2)
- Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial. (PHASE2)
Patents
| Patent | Expiry | Type |
|---|---|---|
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| FDA Orange Book | Patents + exclusivity |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Acid Reflux Relief CI brief — competitive landscape report
- Acid Reflux Relief updates RSS · CI watch RSS
- Pfizer portfolio CI